Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Citius Pharmaceuticals, Inc. (CTXR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Citius Pharmaceuticals, Inc. (CTXR), most recent 12 months reported: net loss $46.27M. Latest balance sheet on file: liquid cash $17.01M. From SEC filings. Others in Pharmaceutical Preparations: Corbus Pharmaceuticals Holdings, Inc. · Corvus Pharmaceuticals, Inc. · Contineum Therapeutics, Inc. · Citius Oncology, Inc. · Curanex Pharmaceuticals Inc · Cadrenal Therapeutics, Inc. · CYTODYN INC. · CYPHERPUNK TECHNOLOGIES INC.

Stock screener

Watchlist